Zura Bio Limited (Nasdaq: ZURA)

#ICYMI: Our CMO, Kiran Nistala, MBBS, PhD, shared his insights with PharmaVoice on the potential to streamline #raredisease drug development. Check out the featured series here: https://lnkd.in/et5482xq

That’s a wrap on an exciting #JPMWeek in San Francisco! #TeamZura made meaningful connections with industry peers, investors, and partners, sharing recent progress on our pipeline of novel dual-pathway antibody candidates and the exciting milestones we anticipate in the year ahead. #JPM25

We’re grateful to have our Phase 2 TibuSURE study featured on the Nasdaq Tower in Times Square! #ICYMI: We recently launched a global Phase 2 study to evaluate tibulizumab in adults with systemic sclerosis (#SSc), a rare autoimmune disease. This marks an important step in advancing potential new treatment options for SSc and supporting those living with this condition. #SystemicSclerosis #ClinicalTrials #TibuSURE #tibulizumab #Nasdaq Photo courtesy of ©2025 Nasdaq, Inc.

Zura Bio Limited (Nasdaq: ZURA) is heading to #JPM25 next week! We’re excited to start the year by connecting with industry peers, partners, and investors to discuss our innovative pipeline of dual-pathway antibody candidates, including the clinical development of #tibulizumab for systemic sclerosis (#SSc) and hidradenitis suppurativa (#HS). See you in San Francisco!

We are pleased to announce the launch of our Phase 2 TibuSURE trial, evaluating the potential of tibulizumab in adults with systemic sclerosis (#SSc). CMO, Kiran Nistala, MBBS, PhD, shares more on this important milestone and reflects on our team’s dedication to advancing potential treatments for this rare and complex rheumatic disease. 🔗 Learn more: https://lnkd.in/ew33Ff-M 🔗 Explore TibuSURE: https://lnkd.in/eDB6Bp3h #SystemicSclerosis #scleroderma #ClinicalTrials #TibuSURE #tibulizumab

As the year comes to a close, all of us at #ZuraBio want to take a moment to express our gratitude to our incredible team, partners, and supporters.    This season highlights the values we hold dear - connection, collaboration, and care - which inspire and guide our mission every day.    Wishing you a holiday season filled with warmth, joy, and meaningful moments with loved ones. May the new year bring health, happiness, and exciting opportunities to create a brighter future together.    #HappyHolidays from all of us at Zura Bio! 

Early diagnosis is key to managing #SystemicSclerosis effectively. Recognizing symptoms early and seeking medical guidance can make a significant difference.   Learn more about the diagnosis journey: https://bit.ly/4haE3Kl

As we gather to celebrate this season of gratitude, we want to extend our heartfelt appreciation to our incredible Zura Bio team and all those who support our mission. Your dedication and passion propel our work forward every day.    Happy #Thanksgiving from Zura Bio! 

Join #TeamZura this December at the Piper Sandler 36th Annual Healthcare Conference! Our senior leaders will share updates on our dual-pathway biologic candidates that have the potential to tackle unmet therapeutic needs.    For full conference details, check out our press release here: https://lnkd.in/eMmefS8h

#SystemicSclerosis (SSc) is a complex #autoimmune disease that can affect anyone, but certain risk factors make some individuals more susceptible. SSc often involves the fibrosis of the skin and may also affect other organs including the heart, lungs, and parts of the digestive system.   Learn more here: https://bit.ly/4faJvLn #DiseaseAwareness #DYK